Innovative Vaccine Approaches
创新疫苗方法
基本信息
- 批准号:10237543
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-23 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibody RepertoireAntibody-mediated protectionAntigen-Antibody ComplexAntigensAntimicrobial ResistanceBiological ModelsCOVID-19 pandemicCanadaClinical TrialsCollaborationsCommunicable DiseasesCommunitiesCoronavirusDiseaseEducational workshopEmerging Communicable DiseasesEnsureEpidemicEventFutureGenomicsHumanImmersionImmuneImmunityImmunologyIn VitroKnowledgeLifeMachine LearningMalignant NeoplasmsMeasuresMethodologyMicrobiologyModelingOutcomePopulationPrivatizationResearchResearch PersonnelRoleSafetySavingsScientistStructureSystemSystems BiologyTechniquesVaccinesVariantaging populationbiomarker identificationclinical practicecostexperiencefrontierglobal healthin vivo Modelinnovationmanufacturabilitynext generationnovelnovel strategiesnovel vaccinespandemic diseaseposterspreventsymposiumtoolvaccine developmentvaccine discoveryvaccinology
项目摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Innovative Vaccine Approaches, organized
by Drs. Mariagrazia Pizza, Galit Alter and Gordon Dougan. The conference will be held in Vancouver, Canada
from June 27- July 1, 2021.
Vaccines have the power to prevent and potentially eradicate a wide range of infectious diseases, representing
one of the most effective life-saving measures at our disposal against global health threats. The recent
coronavirus pandemic has brought the importance and urgency of vaccine development efforts into sharp
focus. Moreover, the vaccinology field is evolving very rapidly, thanks to advances in our understanding of
microbiology, immunology and genomics, as well as advances in structural analysis of antigens and antigen-
antibody complexes and impacts of variation. Over the years, this field has also experienced an elucidation of
mechanisms of immunity and protection, and identification of correlates. However, many questions are still
unsolved and innovative approaches are needed to address new vaccine challenges like antimicrobial
resistance, emerging infectious diseases, cancer and diseases associated with our aging population. This
conference will cover the latest advances and novel approaches towards vaccine development, including: (1)
novel antigen delivery systems; (2) in vitro and in vivo model systems for vaccine appraisal (3) the use of
human challenge models; (4) the role of ‘systems biology’ in the comprehensive analysis of immune correlates,
biomarker identification and safety; (5) machine-learning approaches to define correlations between antibody
repertoires and protection; and (6) strategies for developing low cost vaccines for economically challenged
populations. Together these topics will provide attendees with the new ideas and tools to continue to forge new
frontiers in vaccine capabilities.
摘要
要求为题为创新疫苗办法的Keystone专题讨论会提供支助,
作者:Mariagrazia Pizza、Galit Alter和Gordon Dougan博士。会议将在加拿大的温哥华举行
2021年6月27日至7月1日。
疫苗有能力预防和潜在地根除广泛的传染病,
这是我们应对全球健康威胁的最有效的救生措施之一。近期
冠状病毒大流行使疫苗开发工作的重要性和紧迫性变得更加突出
专心点此外,疫苗学领域正在迅速发展,这要归功于我们对疫苗的理解的进步。
微生物学、免疫学和基因组学,以及抗原和抗原-
抗体复合物和变异的影响。多年来,这一领域也经历了一个澄清,
免疫和保护机制,以及相关因素的识别。然而,许多问题仍然存在。
需要解决未解决的和创新的方法来应对新的疫苗挑战,
耐药性、新出现的传染病、癌症和与我们人口老龄化有关的疾病。这
会议将讨论疫苗开发的最新进展和新方法,包括:(1)
新的抗原递送系统;(2)用于疫苗评估的体外和体内模型系统;(3)使用
人类挑战模型;(4)“系统生物学”在免疫相关性综合分析中的作用,
生物标志物识别和安全性;(5)机器学习方法,以定义抗体之间的相关性
疫苗库和保护;(6)为经济困难的人开发低成本疫苗的战略
人口。这些主题将为与会者提供新的想法和工具,以继续打造新的
疫苗能力的前沿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thale Cross Jarvis其他文献
Thale Cross Jarvis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thale Cross Jarvis', 18)}}的其他基金
Autophagy and Neurodegeneration: Mechanisms to Therapies
自噬和神经退行性变:治疗机制
- 批准号:
10608666 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Malaria: Confronting Challenges From Drug Discovery to Treatment
疟疾:面临从药物发现到治疗的挑战
- 批准号:
10468493 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
Modern Phenotypic Drug Discovery: From Chemical Biology to Therapeutics
现代表型药物发现:从化学生物学到治疗学
- 批准号:
10468419 - 财政年份:2022
- 资助金额:
$ 0.8万 - 项目类别:
相似海外基金
The evolution of dengue virus-reactive circulating antibody repertoire
登革热病毒反应性循环抗体库的进化
- 批准号:
10647572 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
The Anti-Cyclic Citrullinated Protein Antibody Repertoire and Lung Involvement in Rheumatoid Arthritis
类风湿性关节炎中的抗环瓜氨酸蛋白抗体库和肺参与
- 批准号:
10252749 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
Antibody repertoire characterization in the context of coronaviruses
冠状病毒背景下的抗体库表征
- 批准号:
10266227 - 财政年份:2020
- 资助金额:
$ 0.8万 - 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
- 批准号:
10401404 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
- 批准号:
10092085 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
- 批准号:
10578848 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
- 批准号:
9882945 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
- 批准号:
10541163 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Understanding Early-life Influenza Antibody Repertoire Imprinting Through Infection or Vaccination
了解生命早期流感抗体库通过感染或疫苗印记
- 批准号:
10215742 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
- 批准号:
10326846 - 财政年份:2019
- 资助金额:
$ 0.8万 - 项目类别:














{{item.name}}会员




